Blepharitis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (23 intermediate revisions by 5 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Blepharitis is one of the most common [[ocular]] disorders encountered in clinical practice | Blepharitis is one of the most common [[ocular]] disorders encountered in clinical practice and affects more than 180 million people in the United States. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | |||
Blepharitis is one of the most common [[ocular]] disorders encountered by eye care practitioners.<ref name="pmid19277245">{{cite journal| author=Macsai MS| title=The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). | journal=Trans Am Ophthalmol Soc | year= 2008 | volume= 106 | issue= | pages= 336-56 | pmid=19277245 | doi= | pmc=2646454 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19277245 }}</ref> In the United States, blepharitis is estimated to affect more than 180 million people.<ref>Guttman, C. (2009). Recent surveys draw attention to blepharitis. Ophthalmology Times, 34(15), 30-31.</ref> In a United States survey of ophthalmologists and optometrists, it was estimated that 37% and 47% of the patients presented with certain form of blepharitis in clinical practice, respectively.<ref name="pmid19383269">{{cite journal| author=Lemp MA, Nichols KK| title=Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. | journal=Ocul Surf | year= 2009 | volume= 7 | issue= 2 Suppl | pages= S1-S14 | pmid=19383269 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19383269 }} </ref> | |||
===incidence=== | |||
The true incidence of blepharitis remains undetermined. | |||
===Age=== | ===Age=== | ||
Blepharitis can affect all age groups.<ref>Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.</ref><ref>Pflugfelder SC, Karpecki PM, Perez VL. Treatment of blepharitis: recent clinical trials. Ocul Surf. 2014;12(4):273-84.</ref><ref>Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface 2009;7(Suppl 2):S1–14.</ref> A single-center study of patients with chronic blepharitis reported a mean age of 50 years.<ref>McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-80.</ref> Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are relatively young, with a mean age of 42 years.<ref>McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics 1985;25(1):159–72.</ref> | |||
===Gender=== | ===Gender=== | ||
Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are mostly female.<ref>McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics 1985;25(1):159–72.</ref> | |||
===Race=== | ===Race=== | ||
Blepharitis can affect all ethnic groups.<ref>Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.</ref><ref>Pflugfelder SC, Karpecki PM, Perez VL. Treatment of blepharitis: recent clinical trials. Ocul Surf. 2014;12(4):273-84.</ref><ref>Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface 2009;7(Suppl 2):S1–14.</ref> There is no racial predilection for blepharitis. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
Latest revision as of 20:38, 29 July 2020
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis epidemiology and demographics On the Web | |
|
American Roentgen Ray Society Images of Blepharitis epidemiology and demographics | |
|
Risk calculators and risk factors for Blepharitis epidemiology and demographics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Blepharitis is one of the most common ocular disorders encountered in clinical practice and affects more than 180 million people in the United States.
Epidemiology and Demographics
Prevalence
Blepharitis is one of the most common ocular disorders encountered by eye care practitioners.[1] In the United States, blepharitis is estimated to affect more than 180 million people.[2] In a United States survey of ophthalmologists and optometrists, it was estimated that 37% and 47% of the patients presented with certain form of blepharitis in clinical practice, respectively.[3]
incidence
The true incidence of blepharitis remains undetermined.
Age
Blepharitis can affect all age groups.[4][5][6] A single-center study of patients with chronic blepharitis reported a mean age of 50 years.[7] Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are relatively young, with a mean age of 42 years.[8]
Gender
Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are mostly female.[9]
Race
Blepharitis can affect all ethnic groups.[10][11][12] There is no racial predilection for blepharitis.
References
- ↑ Macsai MS (2008). "The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)". Trans Am Ophthalmol Soc. 106: 336–56. PMC 2646454. PMID 19277245.
- ↑ Guttman, C. (2009). Recent surveys draw attention to blepharitis. Ophthalmology Times, 34(15), 30-31.
- ↑ Lemp MA, Nichols KK (2009). "Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment". Ocul Surf. 7 (2 Suppl): S1–S14. PMID 19383269.
- ↑ Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.
- ↑ Pflugfelder SC, Karpecki PM, Perez VL. Treatment of blepharitis: recent clinical trials. Ocul Surf. 2014;12(4):273-84.
- ↑ Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface 2009;7(Suppl 2):S1–14.
- ↑ McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-80.
- ↑ McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics 1985;25(1):159–72.
- ↑ McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics 1985;25(1):159–72.
- ↑ Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.
- ↑ Pflugfelder SC, Karpecki PM, Perez VL. Treatment of blepharitis: recent clinical trials. Ocul Surf. 2014;12(4):273-84.
- ↑ Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface 2009;7(Suppl 2):S1–14.